Mantle Cell Lymphoma Care From Diagnosis Through Relapse: Expert Guidance on Applying the Latest Evidence

Download All
Explore key issues in the management of MCL in this comprehensive program designed to keep you abreast of rapidly evolving treatment strategies. Gain insights on new developments as they emerge with the interactive module, downloadable slideset, short expert commentaries, and an Interactive Decision Support Tool that lets you compare your treatment choices for MCL patient scenarios you enter with those of 5 experts.
Christopher R. Flowers, MD, MS
Julie M. Vose, MD, MBA

ClinicalThought: MCL Management

Induction therapy in mantle cell lymphoma is rapidly evolving. How do you treat your patients with MCL?

Julie M. Vose, MD, MBA Released: April 30, 2018

Ibrutinib and acalabrutinib are both active in relapsed MCL. Read how I consider safety, long-term data, and patient preferences when deciding between these BTK inhibitors.

Christopher R. Flowers, MD, MS Released: August 10, 2018
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by educational grants from
AbbVie
AstraZeneca Pharmaceuticals
Pharmacyclics Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings